Literature DB >> 312010

Exocrine pancreatic function test by a synthetic peptide.

H Harada, K Mishima, T Shundo, N Yamamoto, T Sasaki, T Hinofuji, T Hayashi, Y Uchida, I Kimura.   

Abstract

A new synthetic substance, N-Benzoyl-L-tyrosyl-p-aminobenzoic acid, is specially cleaved by pancreatic chymotrypsin after oral administration and the released p-aminobenzoic acid (P.A.B.A.) is absorbed and excreted in the urine. The P.A.B.A. recovery in the urine was examined to evaluate its diagnostic value as an exocrine pancreatic function test. The data permit the following conclusions: 1. There is a significant correlation between this test and maximal bicarbonate concentration, amylase output and volume of P.Z./C.C.K. secretin test. 2. More than one-half to two-thirds proximal or one-third distal of the pancreas must be removed before one can expect an abnormal result in this test. 3. This is a simple and useful test to detect exocrine pancreatic insufficiency of more than moderate degree but normal results may be obtained in minimal to mild exocrine pancreatic insufficiency. Only six of 11 cases (54.5%) with one abnormal factor of P-S test showed decreased P.A.B.A. recpvery, whereas 22 of 23 cases (95.7%) with two or three abnormal factors of P-S test showed decreased or borderline P.A.B.A. recovery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312010

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.

Authors:  J C Delchier; J C Soule
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

2.  In vitro and in vivo analysis of the PABA test compared with the Lundh test--influence of intraluminal pH.

Authors:  F J Hoek; G T Sanders; A Teunen; G N Tijtgat
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

Review 3.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

4.  Evaluation of postoperative exocrine pancreatic function using chymotrypsin labile peptide.

Authors:  T Manabe; T Yokota; T Tobe
Journal:  Jpn J Surg       Date:  1982

5.  Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.

Authors:  A S Mee; A H Girdwood; E Walker; N H Gilinsky; R E Kottler; I N Marks
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

6.  A controlled study of the exocrine pancreatic function in Sjögren's syndrome and rheumatoid arthritis.

Authors:  C Gobelet; J C Gerster; G Rappoport; C A Hiroz; E Maeder
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

7.  Pancreatic involvement in patients with Sjögren's syndrome and primary biliary cirrhosis.

Authors:  I Nishimori; M Morita; J Kino; M Onodera; Y Nakazawa; K Okazaki; Y Yamamoto; Y Yamamoto
Journal:  Int J Pancreatol       Date:  1995-02

8.  Role of endoscopic elimination of protein plugs in the treatment of chronic pancreatitis.

Authors:  H Harada; H Miyake; H Miki; T Kobayashi; T Sasaki; I Kimura
Journal:  Gastroenterol Jpn       Date:  1982-10

9.  Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Authors:  V S Hubbard; R O Wolf; L A Lester; A C Egge
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.